Perspective Therapeutics (CATX) Change in Acquisitions & Divestments (2015 - 2026)

Perspective Therapeutics has disclosed Change in Acquisitions & Divestments across 10 years of filings, most recently posting $47.6 million for Q1 2026.

• Change in Acquisitions & Divestments for Q1 2026 came in at $47.6 million, up 119.5% year-over-year; the trailing twelve-month figure through Mar 2026 was $25.9 million (down 74.18% YoY), and the FY2024 annual result was $78.7 million, up 245.85% from the prior year.
• Change in Acquisitions & Divestments came in at $47.6 million for Q1 2026 at Perspective Therapeutics, up from -$119.7 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $49.8 million in Q2 2025 to a low of -$119.7 million in Q4 2025.
• The 5-year median for Change in Acquisitions & Divestments is $38.2 million (2024), against an average of $18.0 million.
• Across the five-year window, Change in Acquisitions & Divestments tumbled 395.45% in 2025 and surged 119.5% in 2026, its largest moves.
• Perspective Therapeutics' Change in Acquisitions & Divestments stood at $12.5 million in 2022, then jumped by 81.56% to $22.8 million in 2023, then jumped by 77.93% to $40.5 million in 2024, then sank by 395.45% to -$119.7 million in 2025, then soared by 139.81% to $47.6 million in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $47.6 million (Q1 2026), -$119.7 million (Q4 2025), and $48.2 million (Q3 2025), per Business Quant data.